News

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat ...
One San Francisco-based company aims to find a sustainable alternative by creating plant-based salmon, and with its recent ...
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Senate panel clears ...
The U.S. Food and Drug Administration has declined to approve Capricor Therapeutics' cell therapy for a heart condition, the ...
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
Fuentes Farms LLC announced a voluntary recall of 71 boxes of fresh cucumbers on June 13 due to potential salmonella ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...